Tranah GJ, Giovannucci E, Ma J, Fuchs C, Hankinson SE HD. XRCC2 and XRCC3 polymorphisms are not associated with the risk of colorectal adenoma Cancer.

Alkhubaizi, Q., Khalaf, M. E., Dashti, H., & Sharma PN. The causative etiology includes smoking, tobacco-based addictions, drinking, persistent infections, and poor oral hygiene.

Alkhubaizi Q, Khalaf M, Dashti H, Sharma P. Oral cancer screening among smokers and nonsmokers. J Int Soc Prev Community Dent [Internet]. 2018;8(6):553. Available from: https://journals.lww.com/https://doi.org/10.4103/jispcd.JISPCD_197_18

Abati S, Bramati C, Bondi S, Lissoni A, Trimarchi M. Oral Cancer and Precancer: A Narrative Review on the Relevance of Early Diagnosis. Int J Environ Res Public Health [Internet]. 2020 Dec 8;17(24):9160. Available from: https://www.mdpi.com/1660-4601/17/24/9160

Peacock ZS, Pogrel MA SB. Exploring the reasons for delay in treatment of oral cancer.

Nigam, Kumud; Gupta, Shalini1; Singh, Navin; Yadav, Suresh Kumar; Sanyal S. XRCC3 and NBS1 gene polymorphisms modulate the risk of pre-oral cancer and oral cancer in the North Indian population.

Sabarinath B, Sriram G, Saraswathi TR SB. Immunohistochemical evaluation of mast cells and vascular endothelial proliferation in oral submucous fibrosis.

CB, Das S, Patel H, Adalja C, Kamatchi V VR. Proposed clinical classification for oral submucous fibrosis.

Chung CH, Yang YH, Wang TY, Shieh TY WS. Oral precancerous disorders associated with areca quid chewing, smoking, and alcohol drinking in southern Taiwan.

Passi D, Bhanot P, Kacker D, Chahal D, Atri M PY. Oral submucous fibrosis: Newer proposed classification with critical updates in pathogenesis and management strategies.

Chest (2000) JWR et al. Serum interleukin-10 levels as a prognostic factor in advanced non-small cell lung cancer patients.

Shih CM, Lee YL, Chiou HL, Hsu WF, Chen WE, Chou MC, et al. The involvement of genetic polymorphism of IL-10 promoter in non-small cell lung cancer. Lung Cancer [Internet]. 2005 Dec;50(3):291–7. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0169500205003302

Niazi Y, Thomsen H, Smolkova B, Vodickova L, Vodenkova S, Kroupa M, et al. DNA Repair Gene Polymorphisms and Chromosomal Aberrations in Exposed Populations. Front Genet [Internet]. 2021;12:691947. Available from: http://www.ncbi.nlm.nih.gov/pubmed/34220964

Cadoni G, Boccia S, Petrelli L, Di Giannantonio P, Arzani D GA. A review of genetic epidemiology of head and neck cancer related to polymorphisms in metabolic genes, cell cycle control and alcohol metabolism.

Ide A, Kawasaki E, Abiru N, Sun F, Takahashi R, Kuwahara H, et al. Genetic association between interleukin-10 gene promoter region polymorphisms and type 1 diabetes age-at-onset. Hum Immunol [Internet]. 2002 Aug;63(8):690–5. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0198885902004172

Jurel SK, Gupta DS, Singh RD, Singh M SS. Genes and oral cancer.

A ED, A KK, Sivaperumal P. Single nucleotide polymorphism (SNP’s) as investigative tools for Head and Neck Cancer.

Pekarek L, Garrido-Gil MJ, Sánchez-Cendra A, Cassinello J, Pekarek T, Fraile-Martinez O, García-Montero C, Lopez-Gonzalez L, Rios-Parra A, Álvarez-Mon M, Acero J, Diaz-Pedrero R OM. Emerging histological and serological biomarkers in oral squamous cell carcinoma: Applications in diagnosis, prognosis evaluation and personalized therapeutics.

Chen S, Li Y, Zhu Y, Fei J, Song L, Sun G, et al. SERPINE1 Overexpression Promotes Malignant Progression and Poor Prognosis of Gastric Cancer. J Oncol [Internet]. 2022;2022:2647825. Available from: http://www.ncbi.nlm.nih.gov/pubmed/35132319

Grynchuk FV, Dutka II, Panchuk II, Volkov RA, Sheremet MI, Maksymyuk VV, et al. Justification of Genetic Factors for Predicting the Risk of Acute Bleeding in Peptic Ulcer Disease. J Med Life [Internet]. 2020;13(2):255–9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/32742523

Jeon YJ, Kim YR, Lee BE, Cha SH, Moon MJ, Oh D, et al. Association of five common polymorphisms in the plasminogen activator inhibitor-1 gene with primary ovarian insufficiency. Fertil Steril [Internet]. 2014 Mar;101(3):825–32. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24355042

Tirdea C, Hostiuc S, Moldovan H, Scafa-Udriste A. Identification of Risk Genes Associated with Myocardial Infarction-Big Data Analysis and Literature Review. Int J Mol Sci [Internet]. 2022 Nov 30;23(23). Available from: http://www.ncbi.nlm.nih.gov/pubmed/36499335

Hendrix P, Foreman PM, Harrigan MR, Fisher WS, Vyas NA, Lipsky RH, et al. Association of Plasminogen Activator Inhibitor 1 ( SERPINE1 ) Polymorphisms and Aneurysmal Subarachnoid Hemorrhage. World Neurosurg [Internet]. 2017 Sep;105:672–7. Available from: https://linkinghub.elsevier.com/retrieve/pii/S1878875017308902

Yao Y, Zhou Y, Liu L, Xu Y, Chen Q, Wang Y, et al. Nanoparticle-Based Drug Delivery in Cancer Therapy and Its Role in Overcoming Drug Resistance. Front Mol Biosci [Internet]. 2020;7:193. Available from: http://www.ncbi.nlm.nih.gov/pubmed/32974385

Choi GH, Cho SH, An HJ, Park HS, Lee JY, Ko EJ, et al. Association between PAI-1 Polymorphisms and Ischemic Stroke in a South Korean Case-Control Cohort. Int J Mol Sci [Internet]. 2023 Apr 28;24(9). Available from: http://www.ncbi.nlm.nih.gov/pubmed/37175749

Yende S, Angus DC, Ding J, Newman AB, Kellum JA, Li R, et al. 4G/5G plasminogen activator inhibitor-1 polymorphisms and haplotypes are associated with pneumonia. Am J Respir Crit Care Med [Internet]. 2007 Dec 1;176(11):1129–37. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17761618

Zhang H, Wang M, Shi T, Shen L, Zhu J, Sun M, et al. Genetic polymorphisms of PAI-1 and PAR-1 are associated with acute normal tissue toxicity in Chinese rectal cancer patients treated with pelvic radiotherapy. Onco Targets Ther [Internet]. 2015 Aug;2291. Available from: http://www.dovepress.com/genetic-polymorphisms-of-pai-1-and-par-1-arenbspassociated-with-acute--peer-reviewed-article-OTT

Quinn TJ, Alghamdi J, Padmanabhan S, Porteous DJ, Smith BH, Hocking L, et al. Association between cognition and gene polymorphisms involved in thrombosis and haemostasis. Age (Dordr) [Internet]. 2015 Aug;37(4):9820. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26228839

Shridhar K, Aggarwal A, Walia GK, Gulati S, Geetha AV, Prabhakaran D, Dhillon PK RP. Single nucleotide polymorphisms as markers of genetic susceptibility for oral potentially malignant disorders risk.

Tsai HT, Hsieh MJ, Lin CW, Su SC, Miao NF, Yang SF, Huang HC, Lai FC LY. Combinations of SERPINB5 gene polymorphisms and environmental factors are associated with oral cancer risks.

Warde-Farley D, Donaldson SL, Comes O, Zuberi K, Badrawi R, Chao P, et al. The GeneMANIA prediction server: biological network integration for gene prioritization and predicting gene function. Nucleic Acids Res [Internet]. 2010 Jul;38(Web Server issue):W214–20. Available from: http://www.ncbi.nlm.nih.gov/pubmed/20576703

Szklarczyk D, Gable AL, Lyon D, Junge A, Wyder S, Huerta-Cepas J et al (2019) STRING v11: Protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res 47(D1):D607–D613

Article  CAS  PubMed  Google Scholar 

Mello FW, Miguel AFP, Dutra KL, Porporatti AL, Warnakulasuriya S, Guerra ENS RE. Prevalence of oral potentially malignant disorders.

Venkat A, M SK, R A, K T M AS. Analysis of Oral Leukoplakia and Tobacco-Related Habits in Population of Chengalpattu District.

Pinto AC, Caramês J, Francisco H, Chen A, Azul AM, Marques D. Malignant transformation rate of oral leukoplakia-systematic review. Oral Surg Oral Med Oral Pathol Oral Radiol [Internet]. 2020 Jun;129(6):600–611.e2. Available from: http://www.ncbi.nlm.nih.gov/pubmed/32249069

Prabhu Venkatesh D, Ramalingam K, Ramani P, Krishnan M KVJ. Epidemiological Trends and Clinicopathological Characteristics of Oral Leukoplakia: A Retrospective Analysis From a Single Institution in Chennai, Tamil Nadu, India.

Tsai HT, Hsin CH, Hsieh YH, Tang CH, Yang SF, Lin CW et al. Impact of interleukin-18 polymorphisms -607A/C and -137G/C on oral cancer occurrence and clinical progression.

Didiasova M, Wujak L, Wygrecka M, Zakrzewicz D. From plasminogen to plasmin: role of plasminogen receptors in human cancer. Int J Mol Sci [Internet]. 2014 Nov 17;15(11):21229–52. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25407528

Manders P, Tjan-Heijnen VC, Span PN, Grebenchtchikov N, Geurts-Moespot A, van Tienoven DT et al. Complex of urokinase-type plasminogen activator with its type 1 inhibitor predicts poor outcome in 576 patients with lymph node-negative breast carcinoma.

A AL, B MAW, B WS. S, B CT. S, Bingham SA. Plasminogen activator inhibitor-1 gene polymorphism and colorectal cancer risk and prognosis.

ANTONIS VYLLIOTIS, CHRISTOS YAPIJAKIS, EMEKA NKENKE, THEMISTOKLIS NISYRIOS, DIMITRIOS AVGOUSTIDIS, MARIA ADAMOPOULOU, VASILIOS RAGOS, STAVROS VASSILIOU NK and EV. Effect of Thrombosis-related Gene Polymorphisms upon Oral Cancer: A Regression Analysis.

Tang, Rui, Xiaohong Lyu HL. The 4G/5G polymorphism of plasminogen activator inhibitor type 1 is a predictor of allergic cough.

Li Y, Liu FX, Yuan C, Meng L. Association between plasminogen activator inhibitor gene polymorphisms and osteonecrosis of the femoral head susceptibility: A case-control study. Medicine (Baltimore) [Internet]. 2017 Oct;96(42):e7047. Available from: http://www.ncbi.nlm.nih.gov/pubmed/29049169

Tsai HT, Hsieh MJ, Lin CW, Su SC, Miao NF, Yang SF, et al. Combinations of SERPINB5 gene polymorphisms and environmental factors are associated with oral cancer risks. PLoS One [Internet]. 2017;12(3):e0163369. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28339463

Hendrix P, Foreman PM, Harrigan MR, Fisher WS, Vyas NA, Lipsky RH, et al. Association of Plasminogen Activator Inhibitor 1 (SERPINE1) Polymorphisms and Aneurysmal Subarachnoid Hemorrhage. World Neurosurg [Internet]. 2017 Sep;105:672–7. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28599907

Bentov Y, Brown TJ, Akbari MR, Royer R, Risch H, Rosen B, et al. Polymorphic variation of genes in the fibrinolytic system and the risk of ovarian cancer. PLoS One [Internet]. 2009 Jun 15;4(6):e5918. Available from: http://www.ncbi.nlm.nih.gov/pubmed/19526059

Wang J, Peng Y, Guo H LC. PAI-1 Polymorphisms Have Significant Associations With Cancer Risk, Especially Feminine Cancer.

Cheng RH, Wang YP, Chang JYF, Pan YH, Chang MC, Jeng JH. Genetic Susceptibility and Protein Expression of Extracellular Matrix Turnover-Related Genes in Oral Submucous Fibrosis. Int J Mol Sci [Internet]. 2020 Oct 30;21(21). Available from: http://www.ncbi.nlm.nih.gov/pubmed/33143101

Vairaktaris E, Yapijakis C, Serefoglou Z, Vylliotis A, Ries J, Nkenke E, et al. Plasminogen activator inhibitor-1 polymorphism is associated with increased risk for oral cancer. Oral Oncol [Internet]. 2006 Oct;42(9):888–92. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16730474

Shiratsuchi T, Ishibashi H, Shirasuna K. Inhibition of epidermal growth factor-induced invasion by dexamethasone and AP-1 decoy in human squamous cell carcinoma cell lines. J Cell Physiol [Internet]. 2002 Dec;193(3):340–8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/12384986